Is it safe to administer MR (Measles, Rubella) and DPT (Diphtheria, Pertussis, Tetanus) vaccines 19 days apart?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Safety of Administering MR and DPT Vaccines 19 Days Apart

Yes, it is safe to administer MR (Measles, Rubella) and DPT (Diphtheria, Pertussis, Tetanus) vaccines 19 days apart, as there are no specific contraindications to this timing interval between these particular vaccines.

General Principles for Vaccine Administration Timing

  • The Advisory Committee on Immunization Practices (ACIP) guidelines indicate that inactivated vaccines (like DPT) may be administered at any time before or after a different inactivated or live vaccine (like MR), unless a specific contraindication exists 1
  • Longer-than-recommended intervals between doses do not reduce final antibody concentrations, so an interruption in the immunization schedule does not require reinstitution of the entire series 1
  • The primary concern with timing is for multiple live virus vaccines given by the parenteral route, which should be administered either simultaneously or at least 28 days apart 2

Specific Considerations for MR and DPT Vaccines

  • DPT is an inactivated vaccine while MR contains live attenuated viruses 1
  • The main timing restriction applies to multiple live virus vaccines (such as MMR and varicella) which should be given either on the same day or separated by at least 28 days 2
  • Since DPT is not a live virus vaccine, there is no immunological concern about administering it 19 days after or before MR vaccine 1

Evidence Supporting Safety of This Schedule

  • Simultaneous administration of DTP, MMR, and other vaccines has resulted in seroconversion rates and rates of adverse reactions similar to those observed when the vaccines are administered separately 1, 3
  • Studies have shown that the immunogenicity and reactogenicity of combination vaccines containing DTP components are comparable when administered with or separate from MMR vaccines 4, 5
  • Clinical experience has strengthened the scientific basis for administering vaccines at different intervals without compromising effectiveness or safety 1

Potential Concerns and How to Address Them

  • Certain vaccines (including tetanus toxoid-containing vaccines like DPT) can produce increased rates of local or systemic reactions in certain recipients when administered too frequently due to antigen-antibody complex formation 1
  • However, this concern applies primarily when the same or similar vaccines are given at shorter-than-recommended intervals, not when different types of vaccines are given 19 days apart 1
  • Optimal record keeping, maintaining patient histories, and adhering to recommended schedules can decrease the incidence of such reactions without adversely affecting immunity 1

Best Practices for Administration

  • Document vaccination dates properly to avoid unnecessary revaccination 2
  • Monitor for standard post-vaccination reactions that may occur with either vaccine 6
  • Ensure that the full recommended dose of each vaccine is administered (do not use reduced volumes) 1
  • When possible, use combination vaccines to reduce the number of injections while maintaining appropriate timing 7

Conclusion on Safety

  • The 19-day interval between MR and DPT vaccines does not pose any specific safety concerns based on current immunization guidelines 1
  • This timing will not compromise the effectiveness of either vaccine 1
  • The primary timing restriction (28-day minimum interval) only applies between different live virus vaccines, not between live and inactivated vaccines 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.